Catalyst Wire Dossier Catalyst Wire Dossier

OXTELLAR XR

oxcarbazepine · Supernus Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for OXTELLAR XR, covering 2012-10-19 to 2024-08-14. Get the full timeline:

Most recent: FDA Approved: OXTELLAR XR — Supplemental Application (Supernus Pharmaceuticals, Inc.)

See pricing